UroMed signs up another distributor:
This article was originally published in Clinica
Executive Summary
UroMed, the US manufacturer of stress incontinence devices, has signed up Astra Tech as exclusive distributor for the Reliance urinary control insert in the Nordic countries, the Netherlands and the UK. Astra Tech, a subsidiary of Swedish pharmaceutical company Astra, will invest at least $16 million over five years in marketing the product: the Reliance insert will be launched in stages throughout 1996. The worldwide launch of the product is expected to begin in Germany later this month through marketing partner E Tosse and Co, a subsidiary of Byk Gulden.
You may also be interested in...
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
BMS Has A Strong Pipeline, But Access Challenges Remain
Bristol Myers Squibb’s head of major markets, Monica Shaw, wants to improve patients’ access to lifesaving therapies. And the group has several new products ready to roll.
Novartis Hires Ex-BMS Chief As It Pursues US Growth Strategy
The Swiss pharma company is looking to tap into the experience of ex-BMS leader Giovanni Caforio to help further it US-first commercial strategy.